Cardiovascular risk markers
Evidence is limited. Observational data associates higher ALA intake with modestly lower cardiovascular risk, but trials using ALA-rich oils have not clearly demonstrated the benefit seen with long-chain marine omega-3.
Limited evidence. Early human work, or mostly lab and animal research.
3 sources
- Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease.(opens in a new tab)
Meta-analysis · The Cochrane database of systematic reviews · 2020 · PMID 32114706
- Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease.(opens in a new tab)
Meta-analysis · The Cochrane database of systematic reviews · 2018 · PMID 30019766
- Effect of Alpha-Linolenic Acid Supplementation on Cardiovascular Disease Risk Profile in Individuals with Obesity or Overweight: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.(opens in a new tab)
Meta-analysis · Advances in nutrition (Bethesda, Md.) · 2023 · PMID 37778442
Deep research mode adds each paper’s own conclusion and stated limitations.